INTRODUCTION

•
Immunotherapies have become revolutionary treatment modalities for several malignancies including patients with advanced melanoma and non-small cell lung carcinoma. • New immunotherapy treatments can result in unique adverse events due to increased inflammation in any organ in the body. • Treatment was initiated with methylprednisolone 60mg intravenously every 12 hours with concern for autoimmune hypophysitis related to immunotherapy. Symptoms began improving rapidly with steroid initiation. • Further Endocrine evaluation revealed mild TSH elevation but otherwise normal FSH, LH, Prolactin, and insulin growth factor-1.
DISCUSSION
• This case uniquely exhibits immunotherapy induced isolated ACTH deficiency, rather than hypophysitis.
Hypo physitis can occur with an adverse event rate up to 17% while on Ipilimumab, however isolated ACTH deficiency is rarer.
• Diagnosis is challenging with symptomatology mimicking common malignancy complaints. It is important for all physicians to be able to recognize symptoms of secondary adrenal insufficiency, especially as a side effect of immunotherapy, as this condition is life threatening and requires immediate diagnosis and treatment.
